Black Rock Inc. Geo Vax Labs, Inc. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.4 - $58.5 $165,218 - $24.2 Million	413,047 Added 104042.07%	413,444 $451,000
Q2 2022 Aug 12, 2022	SELL	$9.29 - $34.8 $135,011 - $505,748	-14,533 Reduced 97.34%	397 $0
Q1 2022 May 12, 2022	SELL	$17.25 - $58.95 $12,109 - $41,382	-702 Reduced 4.49%	14,930 $17,000
Q4 2021 Feb 10, 2022	SELL	$52.65 - $71.7 $121,200 - $165,053	-2,302 Reduced 12.84%	15,632 $56,000
Q3 2021 Nov 09, 2021	SELL	$56.4 - $91.35 $21,657 - $35,078	-384 Reduced 2.1%	17,934 $78,000
Q2 2021 Aug 11, 2021	BUY	$64.8 - $94.5 $1.19 Million - $1.73 Million	18,318 New	18,318 $92,000

Ticker GOVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,744,000
Market Cap $51.2M
Description
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.